Vascular Function and the Role of Oxidative Stress in Heart Failure, Heart Transplant, and Beyond

被引:32
|
作者
Witman, Melissa A. H. [1 ,2 ]
Fjeldstad, Anette S. [3 ]
McDaniel, John [1 ,4 ]
Ives, Stephen J. [1 ,2 ]
Zhao, Jia [5 ]
Barrett-O'Keefe, Zachary [1 ,2 ]
Nativi, Jose N. [6 ]
Stehlik, Josef [6 ]
Wray, D. Walter [1 ,2 ,5 ]
Richardson, Russell S. [1 ,2 ,5 ]
机构
[1] George E Whalen VA Med Ctr, Geriatr Res Educ & Clin Ctr, Salt Lake City, UT USA
[2] Univ Utah, Dept Exercise & Sport Sci, Salt Lake City, UT USA
[3] Univ Utah, Dept Neurol, Salt Lake City, UT USA
[4] Kent State Univ, Dept Exercise Sci, Kent, OH 44242 USA
[5] Univ Utah, Sch Med, Dept Internal Med, Div Geriatr, Salt Lake City, UT USA
[6] George E Whalen VA Med Ctr, Dept Internal Med, Div Cardiol, Salt Lake City, UT USA
基金
美国国家卫生研究院;
关键词
antioxidants; flow-mediated vasodilation; vascular health; blood flow; ENDOTHELIUM-DEPENDENT VASODILATION; CHRONIC MYOCARDIAL-INFARCTION; FLOW-MEDIATED DILATION; NITRIC-OXIDE; VITAMIN-C; INDEPENDENT VASODILATION; CARDIAC TRANSPLANTATION; PERIPHERAL VASCULATURE; SUPEROXIDE-DISMUTASE; RELAXING FACTOR;
D O I
10.1161/HYPERTENSIONAHA.112.193318
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Using flow-mediated vasodilation (FMD), reactive hyperemia, and an acute oral antioxidant cocktail (AOC; vitamins C and E and alpha-lipoic acid), this study aimed to provide greater insight into altered vascular function and the role of oxidative stress in chronic heart failure patients with reduced ejection fraction (HFrEF) and at several time points beyond heart transplantation (HTx). A total of 61 age-matched subjects (12 healthy controls, 14 New York Heart Association class II and III HFrEF, and 35 HTx recipients [<3 years post-HTx, 5-10 years post-HTx, and >14 years post-HTx]) ingested either placebo (PL) or an AOC before FMD and reactive hyperemia testing of the brachial artery. Vascular function, as measured by FMD, was not different among the controls (6.8 +/- 1.9%), recent <3-year post-HTx group (8.1 +/- 1.2%), and the 5- to 10-year post-HTx group (5.5 +/- 1.0%). However, PL FMD was lower in the HFrEF (4.5 +/- 0.7%) and in the >14-year post-HTx group (2.9 +/- 0.8%). The AOC increased plasma ascorbate levels in all of the groups but only increased FMD in the controls (PL, 6.8 +/- 1.9%; AOC, 9.2 +/- 1.0%) and >14-year post-HTx recipients (PL, 2.9 +/- 0.8%; AOC, 4.5 +/- 1.3%). There were no differences in reactive hyperemia in any of the groups with PL or AOC. This cross-sectional study reveals that, compared with controls, vascular function is blunted in HFrEF, is similar soon after HTx, but is decreased with greater time post-HTx with free radicals implicated in this progression. (Hypertension. 2012; 60: 659-668.)
引用
收藏
页码:659 / 668
页数:10
相关论文
共 50 条
  • [41] Novel role of AT1 receptor in heart failure and the significance of oxidative stress
    Kim-Mitsuyama, Shokei
    Yamamoto, Eiichiro
    JOURNAL OF CARDIAC FAILURE, 2006, 12 (08) : S152 - S152
  • [42] The Role of miRNA-132 against Apoptosis and Oxidative Stress in Heart Failure
    Liu, Xuelei
    Tong, Zhou
    Chen, Keyan
    Hu, Xiaofang
    Jin, Hongxu
    Hou, Mingxiao
    BIOMED RESEARCH INTERNATIONAL, 2018, 2018
  • [43] Role of Oxidative Stress in Heart Failure: Insights from Gene Transfer Studies
    De Geest, Bart
    Mishra, Mudit
    BIOMEDICINES, 2021, 9 (11)
  • [44] ASSESSMENT OF ENDOTHELIAL FUNCTION AND HEART FAILURE PARAMETERS IN HEART TRANSPLANT AND NON-TRANSPLANT PATIENTS
    Fabrin, H.
    Warnholtz, A.
    Ostad, M. -A.
    Seiler, H.
    Muenzel, T.
    Hink, U.
    TRANSPLANT INTERNATIONAL, 2010, 23 : 18 - 18
  • [45] Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: Role of xanthine oxidase and extracellular superoxide dismutase
    Landmesser, U
    Spiekermann, S
    Dikalov, S
    Wilke, R
    Tatge, H
    Hornig, B
    Drexler, H
    CIRCULATION, 2002, 106 (19) : 571 - 571
  • [46] The Role of Psychological Stress on Heart Autophagy in Mice With Heart Failure
    Lu, Xiao-Ting
    Liu, Xiao-Qiong
    Wang, Bo
    Sun, Yuan-Yuan
    Yang, Rui-Xue
    Xing, Yi-Fan
    Sun, Ping
    Wang, Ying-Bin
    Zhao, Yu-Xia
    PSYCHOSOMATIC MEDICINE, 2017, 79 (09): : 1036 - 1044
  • [47] THE ROLE OF CORONARY VASCULAR RAREFACTION IN HEART FAILURE
    Hardell, Davis
    Fopiano, Katie Anne
    Patel, Vijay
    Bagi, Zsolt
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 462 - 462
  • [48] Role of Vascular Disease in the Evolution of Heart Transplant Patients
    Bos, L.
    Mirabet, S.
    Brossa, V.
    Lopez, L.
    Sionis, A.
    Capellades, H.
    Cinca, J.
    Roig, E.
    TRANSPLANTATION PROCEEDINGS, 2015, 47 (08) : 2393 - 2394
  • [49] The role of oxidative stress in the genesis of heart disease
    Singal, PK
    Khaper, N
    Palace, V
    Kumar, D
    CARDIOVASCULAR RESEARCH, 1998, 40 (03) : 426 - 432
  • [50] Imaging for the Assessment of Heart Failure in Congenital Heart Disease: Ventricular Function and Beyond
    Burchill, Luke J.
    Mertens, Luc
    Broberg, Craig S.
    HEART FAILURE CLINICS, 2014, 10 (01) : 9 - +